Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Kierszenbaum, F.; Wirth, J.J.; McCann, P.P.; Sjoerdsma, A.
    Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells (1987), Proc. Natl. Acad. Sci. USA, 84, 4278-4282.
    View publication on PubMedView publication on EuropePMC

Inhibitors

EC Number Inhibitors Comment Organism Structure
4.1.1.19 (E)-alpha-Monofluoromethyl-3-4-dehydroarginine irreversible inhibitor may have a potential application in chemotherapy against Trypanosoma cruzi infection Trypanosoma cruzi
4.1.1.19 DL-alpha-difluoromethylarginine irreversible inhibitor may have a potential application in chemotherapy against Trypanosoma cruzi infection Trypanosoma cruzi
4.1.1.19 Monofluoromethylagmatine irreversible inhibitor may have a potential application in chemotherapy against Trypanosoma cruzi infection Trypanosoma cruzi

Organism

EC Number Organism UniProt Comment Textmining
4.1.1.19 Trypanosoma cruzi
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
4.1.1.19 L-arginine
-
Trypanosoma cruzi agmatine + CO2
-
?